Publications
ASID publications available to the public.
-
ASID is a Company Limited by Guarantee (ACN 155 632 698) registered with the Australian Securities and Investment Commission and Australian Charities and Not-for-profits Commission. We invite you to explore our annual reports, featuring President’s Reports, information on our advocacy activities, events, awards and grants, member achievements, as well as the audited accounts.
-
This resource is for anyone interested in paediatric infectious diseases. Journal articles are submitted by ANZPID members along with a quiz. Trainees are encouraged to participate.
-
2023
Healthcare-Associated Infections in Australia: Principles and Practice of Infection Prevention and Control.
Endorsed by ASID, with ASID member Professor Ramon Z. Shaban Editor in Chief.Non-occupational post-exposure prophylaxis (nPEP)
This guideline represents a stepwise approach for managing children at risk of blood-borne infections and where relevant, sexually transmitted infections, following non-occupational exposure to body-fluids.2022
Management of Perinatal Infections
These perinatal guidelines are funded by ASID. Third Edition. November 2022. Editors: Pamela Palasanthiran, Mike Starr, Cheryl Jones and Michelle Giles.Australian consensus recommendations for the management of hepatitis B infection.
ASID endorsed the consensus statement developed by the Gastroenterological Society of Australia that summarised the management of hepatitis B in Australia in 2022.2021
2021 Australian Guidelines for diabetes-related foot disease
ASID endorsed the new Diabetes Feet Australia (DFA) guidelines for diabetes-related foot disease.HCV in Children: Australian Commentary on AASLD-IDSA Guidance
ASHM convened the committee which included representatives from GESA, ASID, Hepatitis Australia and Primary Care to develop the guidance in October 2021.2016
Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines June 2016. Developed by the ANZPID Australasian Stewardship of Antimicrobials in Paediatrics (ASAP).